Designing Quality: From Inspection Readiness to Predicting Risk Before First Patient

RBQMLive 2026 · On-Demand

Explore how organizations are using historical study data and protocol intelligence to anticipate quality risks—and design them out before first patient in. This panel examines how earlier risk visibility supports better planning, more predictable study execution and continuous inspection readiness.

Featuring: 

• Kris Luypaert, Merck KGaA

• Tom Whitman, Biogen

• Moderated by: Richard Young, CluePoints